Higher caseload improves cervical cancer survival in patients treated with brachytherapy

被引:19
|
作者
Lee, Moon-Sing [1 ,4 ]
Tsai, Shiang-Jiun [1 ]
Lee, Ching-Chih [2 ,4 ]
Su, Yu-Chieh [3 ,4 ]
Chiou, Wen-Yen [1 ,4 ]
Lin, Hon-Yi [1 ,4 ]
Hung, Shih-Kai [1 ,4 ]
机构
[1] Buddhist Dalin Tzu Chi Hosp, Dept Radiat Oncol, Chiayi, Taiwan
[2] Buddhist Dalin Tzu Chi Hosp, Dept Otolaryngol, Chiayi, Taiwan
[3] Buddhist Dalin Tzu Chi Hosp, Dept Hematol Oncol, Chiayi, Taiwan
[4] Tzu Chi Univ, Sch Med, Hualien, Taiwan
来源
RADIATION ONCOLOGY | 2014年 / 9卷
关键词
HOSPITAL VOLUME; PROPENSITY SCORES; SURGERY; IMPACT; RATES;
D O I
10.1186/s13014-014-0234-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: Increased caseload has been associated with better patient outcomes in many areas of health care, including high-risk surgery and cancer treatment. However, such a positive volume vs. outcome relationship has not yet been validated for cervical cancer brachytherapy. The purpose of this study was to examine the relationship between physician caseload and survival rates in cervical cancer treated with brachytherapy using population-based data. Methods: Between 2005 and 2010, a total of 818 patients were identified using the Taiwan National Health Insurance Research Database. Multivariate analysis using a Cox proportional hazards model and propensity scores was used to assess the relationship between 5-year survival rates and physician caseloads. Results: As the caseload of individual physicians increased, unadjusted 5-year survival rates increased (P = 0.005). Using a Cox proportional hazard model, patients treated by high-volume physicians had better survival rates (P = 0.03), after adjusting for comorbidities, hospital type, and treatment modality. When analyzed by propensity score, the adjusted 5-year survival rate differed significantly between patients treated by high/medium-volume physicians vs. patients treated by low/medium-volume physicians (60% vs. 54%, respectively; P = 0.04). Conclusions: Provider caseload affected survival rates in cervical cancer patients treated with brachytherapy. Both Cox proportional hazard model analysis and propensity scores showed association between high/medium volume physicians and improved survival.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Reducing dose to rectum by placement of a rectum-emptying tube in cervical cancer patients treated with brachytherapy
    Ferre, Marjorie
    Cagetti, Leonel Varela
    Zemmour, Christophe
    Tyran, Marguerite
    Fau, Pierre
    Chargari, Cyrus
    Tallet, Agnes
    Gonzague, Laurence
    Annede, Pierre
    [J]. BRACHYTHERAPY, 2021, 20 (04) : 748 - 754
  • [42] Effect of neuraxial anaesthesia on tumour progression in cervical cancer patients treated with brachytherapy: a retrospective cohort study
    Ismail, H.
    Ho, K. M.
    Narayan, K.
    Kondalsamy-Chennakesavan, S.
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 2010, 105 (02) : 145 - 149
  • [43] Survival outcome of cervical cancer patients treated by image-guided brachytherapy: a 'real world' single center experience in Thailand from 2008 to 2018
    Tharavichitkul, Ekkasit
    Jia-Mahasap, Bongkot
    Muangwong, Pooriwat
    Chakrabandhu, Somvilai
    Klunklin, Pitchayaponne
    Onchan, Wimrak
    Tippanya, Damrongsak
    Nobnop, Wannapa
    Watcharawipha, Anirut
    Kittidachanan, Kittikun
    Galalae, Ravan M.
    Chitapanarux, Imjai
    [J]. JOURNAL OF RADIATION RESEARCH, 2022, 63 (04) : 657 - 665
  • [44] Intraoperative preplanning improves implant quality and biochemical disease-free survival in patients treated with permanent prostate brachytherapy
    Ennis, RD
    Wuu, CS
    Vecchio, D
    Liu, T
    Gewanter, RM
    Katz, AE
    [J]. JOURNAL OF UROLOGY, 2003, 169 (04): : 446 - 447
  • [45] Survival of patients with untreated cervical cancer
    Adriano, EM
    Harrison, TA
    Riffenburgh, RH
    Johnstone, PAS
    [J]. CANCER JOURNAL, 2001, 7 (06): : 542 - 542
  • [46] Survival analysis of cervical cancer patients
    Pardo, Constanza
    Cendales, Ricardo
    [J]. BIOMEDICA, 2009, 29 (03): : 437 - 447
  • [47] Increased bone marrow SUVmax on 18F-FDG PET is associated with higher pelvic treatment failure in patients with cervical cancer treated by chemoradiotherapy and brachytherapy
    Seban, Romain-David
    Robert, Charlotte
    Dercle, Laurent
    Yeh, Randy
    Dunant, Ariane
    Reuze, Sylvain
    Schernberg, Antoine
    Sun, Roger
    Mignot, Fabien
    Terroir, Marie
    Schlumberger, Martin
    Haie-Meder, Christine
    Chargari, Cyrus
    Deutsch, Eric
    [J]. ONCOIMMUNOLOGY, 2019, 8 (05):
  • [48] Quality of life of oropharyngeal cancer patients treated with brachytherapy
    David N. Teguh
    Peter C. Levendag
    Inger-Karine Kolkman-Deurloo
    Peter van Rooij
    Paul I. M. Schmitz
    [J]. Current Oncology Reports, 2009, 11 : 143 - 150
  • [49] Survival of Low-Risk and Intermediate-Risk Prostate Cancer Patients Treated with IMRT Or Brachytherapy
    Podder, T.
    Dey, A.
    Datta, S.
    Biswas, T.
    [J]. MEDICAL PHYSICS, 2020, 47 (06) : E318 - E318
  • [50] The impact of brachytherapy boost and radiotherapy treatment duration on survival in patients with vaginal cancer treated with definitive chemoradiation
    Reshko, Leonid B.
    Gaskins, Jeremy T.
    Metzinger, Daniel S.
    Todd, Sarah L.
    Eldredge-Hindy, Harriet B.
    Silva, Scott R.
    [J]. BRACHYTHERAPY, 2021, 20 (01) : 75 - 84